Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2009
10/15/2009US20090258919 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258900 Amide derivative
10/15/2009US20090258821 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
10/15/2009US20090258421 Embryonic stem cells and neural progenitor cells derived therefrom
10/15/2009US20090258049 Drug eluting expandable devices
10/15/2009US20090258017 Lyophilized therapeutic peptibody Formulations
10/15/2009US20090257995 Harmful bacterium control agent containing bacillus thuringiensis
10/15/2009US20090257950 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2721060A1 Inhibitors of fatty acid amide hydrolase
10/15/2009CA2721051A1 Aminosugar compound and process for production thereof
10/15/2009CA2720774A1 Materials and methods for improved immunoglycoproteins
10/15/2009CA2719279A1 Functionalized polysiloxanes, method of preparing same and uses thereof
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108367A1 Composition for amelioration/prevention of adverse side effect in steroid therapy
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1474158B1 Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1331950B1 Ex vivo methods and compositions for nucleic acid delivery
10/14/2009EP1303302B1 Use of strains of the parapox ovis virus against organ fibrosis
10/14/2009EP1139793B1 Inhibitors of the bitter taste response
10/14/2009CN101558071A Substituted quinazolines
10/14/2009CN101558038A Novel curcumin derivative
10/14/2009CN101557826A Therapeutic agent for urinary tract disease
10/14/2009CN101557811A Use of dipeptidyl peptidase IV inhibitors for preventing, delaying or reducing the occurance of edema
10/14/2009CN101555283A Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
10/14/2009CN101554382A New purpose of triterpene substance
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
10/14/2009CN100549005C Optically active dihydropyridine derivative
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548993C Salts of valsartan
10/14/2009CN100548977C Prostaglandin-like compound and its uses for treatment of external secretion disorders
10/14/2009CN100548375C Antitumor effect potentiators
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548302C Female hormone-containing patch
10/14/2009CN100548299C Excitatory amino acid receptor antagonists
10/14/2009CN100548291C MCH antagonists for the treatment of obesity
10/14/2009CN100548283C Prevention and treatment of androgen-deprivation induced osteoporosis
10/14/2009CN100548144C Animal beverage
10/13/2009US7601868 Such as 4-(cyclopropylmethoxy)-N-(2-{4-[1-(1-pyrrolidinyl)ethyl]phenyl}ethyl)benzamide having melanin-concentrating hormone antagonistic action, for prophylaxis and/or treatment of obesity
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601746 Such as 3-{2,6-difluoro-4-[4,5-dihydro-6-(3,3-dimethylbutyl)naphtho[1,2-d]thiazol-2-ylcabamoyl)phenyl]-2-methylacrylic acid
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601720 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601710 Preparation of hymenialdisine derivatives and use thereof
10/13/2009US7601703 Complexing the target cell with therapeutic agent; antiproliferative agent
10/13/2009US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides
10/13/2009US7601488 Hyaluronic acid oligosaccharide fractions and drugs containing the same
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009US7601157 Devices and methods for the restoration of a spinal disc
10/13/2009CA2482405C Multiple compartment bag assembly for dialysis fluid
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2470484C A combination comprising combretastatin and anticancer agents
10/13/2009CA2455298C Condensed polycyclic compounds
10/13/2009CA2455246C Drug preparation comprising .alpha.-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ace) and its use for the treatment of neurodegenerative diseases
10/13/2009CA2454022C Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis
10/13/2009CA2428160C Compositions for antitumor treatment containing ecteinascidin 743
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2384037C Pyrazolo[4,3-d]pyrimidines
10/13/2009CA2379666C Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
10/13/2009CA2373867C Compositions comprising organosiloxane resins for delivering oral care substances
10/13/2009CA2370830C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
10/13/2009CA2370388C Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonylphenyl)ethyl)benzamide
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/13/2009CA2292775C Cyanoguanidines as cell proliferation inhibitors
10/13/2009CA2291218C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/13/2009CA2264552C Method of using tetracycline compounds for inhibition of nitric oxide production
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2222513C Agents binding specifically to biotin for detecting damaged nucleic acid bases
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/08/2009WO2009123896A1 Pyridyl derivatives as cftr modulators
10/08/2009WO2009123588A1 Amides of 3, 5-substituted-is0xaz0le-4-carb0xylic acids for the treatment of viral infections, cancer and restenosis
10/08/2009WO2009123575A1 A photosensitising composition and its uses
10/08/2009WO2009123364A1 Mineral absorption accelerator and iron deficiency anemia improver or food composition
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof
10/08/2009WO2009123211A1 Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents
10/08/2009WO2009123210A1 Preventive and/or remedy for vascular diseases
10/08/2009WO2009123206A1 Oral pharmaceutical composition
10/08/2009WO2009123194A1 Heterocyclic compound
10/08/2009WO2009123164A1 Heterocyclic derivative having inhibitory activity on endothelial lipase
10/08/2009WO2009123119A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009WO2009122719A1 Substance and composition both capable of imparting heat resistance
10/08/2009WO2009122710A1 Medical composition
10/08/2009WO2009122667A1 Therapeutic for hepatic cancer
10/08/2009WO2009122639A1 Abc transporter protein expression inhibitor
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 1564